Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet LEVODOPA/BENSERAZIDE TEVA 200mg / 50mg tablets
- Product code:
- W54607002
- Quantity:
- 30
- Indicated for:
- Parkinson's disease
- Route of administration:
- oral
- Substance:
- levodopa + benserazide (antiparkinsonian agents)
- ATC
- N04BA02 — Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Levodopa + Benserazide is a combination medication used in the treatment of Parkinson's disease and parkinsonian syndromes. Levodopa is a precursor of dopamine, which helps compensate for the dopamine deficiency in the brain characteristic of these conditions. Benserazide is a peripheral decarboxylase inhibitor that prevents levodopa from being converted into dopamine outside the brain, thereby increasing the treatment's effectiveness and reducing side effects.
This combination helps alleviate symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and balance difficulties. It is important to take the medication as prescribed by a doctor, with the dosage gradually adjusted to minimize side effects.
Side effects may include nausea, vomiting, dizziness, drowsiness, or motor fluctuations (such as 'on-off' phenomena). In rare cases, hallucinations or mood changes may occur. Regular medical monitoring is essential to adjust the treatment based on the progression of the disease.
This combination helps alleviate symptoms such as tremors, muscle rigidity, bradykinesia (slowness of movement), and balance difficulties. It is important to take the medication as prescribed by a doctor, with the dosage gradually adjusted to minimize side effects.
Side effects may include nausea, vomiting, dizziness, drowsiness, or motor fluctuations (such as 'on-off' phenomena). In rare cases, hallucinations or mood changes may occur. Regular medical monitoring is essential to adjust the treatment based on the progression of the disease.
General data about LEVODOPA/BENSERAZIDE TEVA 200mg / 50mg
- Substance:
- levodopa + benserazide
- Date of latest medicines list:
- 01-07-2015
- Product code:
- W54607002
- Concentration:
- 200mg / 50mg
- Pharmaceutical form:
- tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for levodopa + benserazide
Concentrations available for levodopa + benserazide
- 100mg/25mg
- 200mg/50mg